We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDS
11651
PUT
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$162K ﹤0.01%
+69,500
New +$198K
XPOA
11652
CALL
DELISTED
DPCM Capital, Inc.
XPOA
$162K ﹤0.01%
+16,500
New +$162K
ACR
11653
CALL
ACRES Commercial Realty
ACR
$99.6M
$161K ﹤0.01%
12,900
-2,600
-17% -$37.7K
PAYO icon
11654
Payoneer
PAYO
$2.41B
$161K ﹤0.01%
21,893
+5,747
+36% +$44.2K
YCBD.PRA
11655
DELISTED
cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
$161K ﹤0.01%
+26,921
New +$165K
KT icon
11656
KT
KT
$9.35B
$160K ﹤0.01%
12,746
-47,407
-79% -$621K
RELL icon
11657
Richardson Electronics
RELL
$263M
$160K ﹤0.01%
+11,832
New +$137K
CFB
11658
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$160K ﹤0.01%
+10,232
New +$149K
PTNR
11659
DELISTED
Partner Communications
PTNR
$160K ﹤0.01%
+19,879
New +$115K
EVFM
11660
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$160K ﹤0.01%
28,107
-11,840
-30% -$101K
GSS
11661
PUT
DELISTED
Golden Star Resources Ltd.
GSS
$160K ﹤0.01%
41,700
-5,000
-11% -$17K
ACHV icon
11662
CALL
Achieve Life Sciences
ACHV
$834M
$159K ﹤0.01%
+20,500
New +$161K
CMCT
11663
Creative Media & Community Trust
CMCT
$11.5M
$159K ﹤0.01%
+1
New +$193K
CDAK
11664
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$159K ﹤0.01%
+14,292
New +$198K
FTPAU
11665
DELISTED
FTAC Parnassus Acquisition Corp. Unit
FTPAU
$159K ﹤0.01%
16,200
CPSH icon
11666
PUT
CPS Technologies
CPSH
$73.7M
$158K ﹤0.01%
41,800
-30,000
-42% -$133K
EGY icon
11667
PUT
Vaalco Energy
EGY
$607M
$158K ﹤0.01%
49,300
-32,600
-40% -$108K
FORA
11668
DELISTED
Forian
FORA
$158K ﹤0.01%
17,475
+1,309
+8% +$12.5K
PRPH
11669
CALL
DELISTED
ProPhase Labs
PRPH
$158K ﹤0.01%
2,210
+240
+12% +$14.9K
REVG
11670
CALL
DELISTED
REV Group
REVG
$158K ﹤0.01%
11,200
-5,300
-32% -$83.8K
TRTX
11671
CALL
TPG RE Finance Trust
TRTX
$593M
$158K ﹤0.01%
12,800
+400
+3% +$5.09K
WYY icon
11672
WidePoint Corp
WYY
$99.9M
$158K ﹤0.01%
+40,216
New +$190K
QTTB icon
11673
CALL
Q32 Bio
QTTB
$447M
$158K ﹤0.01%
2,411
+1,578
+189% +$153K
VOXX
11674
CALL
DELISTED
VOXX International Corporation Class A
VOXX
$158K ﹤0.01%
15,500
-47,900
-76% -$533K
DSKE
11675
PUT
DELISTED
Daseke, Inc. Common Stock
DSKE
$158K ﹤0.01%
15,700
-8,000
-34% -$78.6K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.